CXCL10 and COVID-19: This prospective study provides an in-depth immunological characterization of the spike-specific response following the third dose of COVID-19 vaccination in PwMS undergoing different DMTs by evaluating soluble biomarkers beyond IFN-γ, including IL-2, TNF-α and IP-10, as surrogate markers of the cell-mediated response.